ARCHIVES

Finasteride Cut Risk Of Prostate Cancer In Large Trial, But Value In Clinic Unclear.

This article is from The Cancer Letter archive.

Vol. 29 No. 26 | June 27, 2003

Download PDF Visit The Full Archive

Related Articles

In Brief: Foundation Gives Georgetown $2.9 Million For Pediatric Lab, To Be Headed By Cairo

February 6, 1998

MUSC Hollings Cancer Center awarded NCI designation

February 1, 2021

NCI RFAs Available

May 5, 2000

Advisors approve set-aside for alternative medicine “best case series.”

November 19, 2004

ACS Research Grants Hit $78.2 Million

July 18, 1986

In Brief: Pass Joins Karmanos Cancer Institute; Nag President-Elect, Brachytherapy Society

June 27, 1997